\-\ Texto\\:\\ \ \(0\)\
\-\ surgery\ \(977\)\
\-\ thicken\\ gall\\ bladder\\ wall\\ with\\ no\\ stones\\.\\ \\ no\\ intrahepatic\\ or\\ extrahepatic\\ duct\\ dilation\\ or\\ pericholecystic\\ fluid\\.\\ \\ sonographic\\ murphy\\â\\€\\™s\\ positive\\.\\ \\ hida\\ showed\\ no\\ uptake\\ in\\ gallbladder\ \(0\)\
\-\ acalculous\\ acute\\ cholecystitis\ \(1\)\
\-\ wall\\ thickening\\ differential\\ includes\\ acute\\ cholecystitis\\,\\ ascities\\,\\ heart\\ failure\\,\\ and\\ hypoalbuminemia\\.\\ \\ hida\\ false\\ positive\\ can\\ be\\ seen\\ in\\ patients\\ with\\ hyperalimentation\\,\\ severe\\ illness\\,\\ and\\ hepatocellular\\ dysfunction\\.\ \(0\)\
\-\ 57\\ y\\/o\\ male\\ with\\ right\\ upper\\ quadrant\\ pain\\ and\\ history\\ of\\ spine\\ surgery\\ and\\ opioid\\ use\\.\ \(1\)\
\-\ acute\\ cholecystitis\\ is\\ associated\\ with\\ cholelithiasis\\ in\\ about\\ 90\\-95\\%\\ of\\ the\\ cases\\.\\ \\ acalculous\\ cholecystitis\\ is\\ typically\\ seen\\ in\\ the\\ setting\\ of\\ icu\\ patients\\ with\\ chronic\\ severe\\ disease\\.\\ \\ \\ however\\,\\ a\\ small\\ group\\ of\\ patients\\ present\\ with\\ acalculous\\ cholecystitis\\ from\\ the\\ outpatient\\ setting\\.\\ \\ this\\ group\\ \\ includes\\ children\\ and\\ patients\\ who\\ have\\ a\\ history\\ of\\ prolong\\ fasting\\,\\ diabetes\\ or\\ opioid\\ use\\.\\ \\ cholecystitis\\ is\\ rare\\ in\\ children\\ but\\ up\\ to\\ 50\\%\\ of\\ the\\ cases\\ are\\ of\\ acalculous\\.\\ \\ biliary\\ stasis\\,\\ ischemia\\,\\ inflammation\\ and\\ trauma\\ are\\ thought\\ to\\ contribute\\ to\\ these\\ cases\\.\ \(0\)\
\-\ treatment\\ is\\ surgery\\,\\ which\\ occurred\\ in\\ this\\ case\\.\\ \\ pathology\\ confirmed\\ diagnosis\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ acalculous\\:\\ 0\\.1409150415366397\ \(0\)\
\-\ cholecystitis\\:\\ 0\\.13965699399847517\ \(0\)\
\-\ opioid\\:\\ 0\\.07619716987534982\ \(0\)\
\-\ hida\\:\\ 0\\.06679931621510207\ \(0\)\
\-\ group\\:\\ 0\\.04560072381025104\ \(0\)\
\-\ patients\\:\\ 0\\.04536563280750822\ \(0\)\
\-\ setting\\:\\ 0\\.044263679524474187\ \(0\)\
\-\ cases\\:\\ 0\\.04379709021509435\ \(0\)\
\-\ ascities\\:\\ 0\\.03957387761691481\ \(0\)\
\-\ 90\\-95\\:\\ 0\\.03957387761691481\ \(0\)\
\-\ thicken\\:\\ 0\\.03809858493767491\ \(0\)\
\-\ hypoalbuminemia\\:\\ 0\\.03809858493767491\ \(0\)\
\-\ hyperalimentation\\:\\ 0\\.03809858493767491\ \(0\)\
\-\ prolong\\:\\ 0\\.03809858493767491\ \(0\)\
\-\ children\\:\\ 0\\.03786209686731527\ \(0\)\
\-\ includes\\:\\ 0\\.03533210662398806\ \(0\)\
\-\ fasting\\:\\ 0\\.035228760384159924\ \(0\)\
\-\ use\\:\\ 0\\.03464040117993131\ \(0\)\
\-\ acute\\:\\ 0\\.03245968198625378\ \(0\)\
\-\ surgery\\:\\ 0\\.031923062528619615\ \(0\)\
\-\ contribute\\:\\ 0\\.0298450571816026\ \(0\)\
\-\ stasis\\:\\ 0\\.02959485121150295\ \(0\)\
\-\ extrahepatic\\:\\ 0\\.0289100748390695\ \(0\)\
\-\ gall\\:\\ 0\\.028700731277427165\ \(0\)\
\-\ positive\\:\\ 0\\.028439852208042224\ \(0\)\
\-\ pericholecystic\\:\\ 0\\.027765748934894065\ \(0\)\
\-\ false\\:\\ 0\\.027765748934894065\ \(0\)\
\-\ murphy\\:\\ 0\\.027276978782051372\ \(0\)\
\-\ severe\\:\\ 0\\.026967280000676965\ \(0\)\
\-\ icu\\:\\ 0\\.026163827473139438\ \(0\)\
\-\ intrahepatic\\:\\ 0\\.025801686102811472\ \(0\)\
\-\ wall\\:\\ 0\\.025386247387064062\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.025249733978748058\ \(0\)\
\-\ outpatient\\:\\ 0\\.024944998489154206\ \(0\)\
\-\ illness\\:\\ 0\\.024385002120102972\ \(0\)\
\-\ cholelithiasis\\:\\ 0\\.024385002120102972\ \(0\)\
\-\ 57\\:\\ 0\\.023880181233881158\ \(0\)\
\-\ dysfunction\\:\\ 0\\.023347889984231707\ \(0\)\
\-\ occurred\\:\\ 0\\.0232054306811185\ \(0\)\
\-\ stones\\:\\ 0\\.022547065723948205\ \(0\)\
\-\ biliary\\:\\ 0\\.022131839762237093\ \(0\)\
\-\ diabetes\\:\\ 0\\.02169513305279962\ \(0\)\
\-\ sonographic\\:\\ 0\\.021244561997459444\ \(0\)\
\-\ gallbladder\\:\\ 0\\.021056349859764945\ \(0\)\
\-\ dilation\\:\\ 0\\.020656547082997193\ \(0\)\
\-\ \\%\\:\\ 0\\.020444318290728285\ \(0\)\
\-\ ischemia\\:\\ 0\\.02036580173080978\ \(0\)\
\-\ thought\\:\\ 0\\.0201677769301545\ \(0\)\
\-\ duct\\:\\ 0\\.02009065961033634\ \(0\)\
\-\ inflammation\\:\\ 0\\.01863453781371494\ \(0\)\
\-\ pathology\\:\\ 0\\.01793537656472965\ \(0\)\
\-\ bladder\\:\\ 0\\.017786722529482202\ \(0\)\
\-\ uptake\\:\\ 0\\.017410171408688266\ \(0\)\
\-\ seen\\:\\ 0\\.01731925759043785\ \(0\)\
\-\ failure\\:\\ 0\\.017166452732468546\ \(0\)\
\-\ rare\\:\\ 0\\.017017180506016902\ \(0\)\
\-\ about\\:\\ 0\\.016892602595406418\ \(0\)\
\-\ 50\\:\\ 0\\.01667178470073746\ \(0\)\
\-\ confirmed\\:\\ 0\\.016478972323522037\ \(0\)\
\-\ typically\\:\\ 0\\.015468850100030627\ \(0\)\
\-\ quadrant\\:\\ 0\\.015422440687107972\ \(0\)\
\-\ or\\:\\ 0\\.015408042291749347\ \(0\)\
\-\ heart\\:\\ 0\\.015226049481583457\ \(0\)\
\-\ thickening\\:\\ 0\\.014854484972786419\ \(0\)\
\-\ spine\\:\\ 0\\.01443130023592486\ \(0\)\
\-\ showed\\:\\ 0\\.014368221886788188\ \(0\)\
\-\ differential\\:\\ 0\\.013912614509502203\ \(0\)\
\-\ \\,\\:\\ 0\\.013882567462424993\ \(0\)\
\-\ no\\:\\ 0\\.013237602318520031\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.013097573023822851\ \(0\)\
\-\ in\\:\\ 0\\.012966068619700153\ \(0\)\
\-\ s\\:\\ 0\\.012568039318536344\ \(0\)\
\-\ fluid\\:\\ 0\\.01245455951078899\ \(0\)\
\-\ chronic\\:\\ 0\\.012343536579010257\ \(0\)\
\-\ however\\:\\ 0\\.012201887464600361\ \(0\)\
\-\ y\\/o\\:\\ 0\\.012136559127280209\ \(0\)\
\-\ history\\:\\ 0\\.01210476448930342\ \(0\)\
\-\ trauma\\:\\ 0\\.011984660419271431\ \(0\)\
\-\ are\\:\\ 0\\.011947424333636941\ \(0\)\
\-\ up\\:\\ 0\\.011783831543867812\ \(0\)\
\-\ is\\:\\ 0\\.011534169813020013\ \(0\)\
\-\ who\\:\\ 0\\.011425479021239497\ \(0\)\
\-\ these\\:\\ 0\\.011404331753629949\ \(0\)\
\-\ upper\\:\\ 0\\.010574771822403684\ \(0\)\
\-\ associated\\:\\ 0\\.010340833650808727\ \(0\)\
\-\ small\\:\\ 0\\.010095257868621121\ \(0\)\
\-\ diagnosis\\:\\ 0\\.010062663234771384\ \(0\)\
\-\ can\\:\\ 0\\.00993960180753369\ \(0\)\
\-\ present\\:\\ 0\\.009897480789393235\ \(0\)\
\-\ this\\:\\ 0\\.009857817572452647\ \(0\)\
\-\ case\\:\\ 0\\.009587202219832157\ \(0\)\
\-\ have\\:\\ 0\\.009489426042897906\ \(0\)\
\-\ but\\:\\ 0\\.009346170774530963\ \(0\)\
\-\ treatment\\:\\ 0\\.008869830562055831\ \(0\)\
\-\ which\\:\\ 0\\.00818022865252589\ \(0\)\
\-\ male\\:\\ 0\\.007924130963525504\ \(0\)\
\-\ disease\\:\\ 0\\.007162756621618996\ \(0\)\
\-\ be\\:\\ 0\\.006757726786379124\ \(0\)\
\-\ to\\:\\ 0\\.006570278591430558\ \(0\)\
\-\ from\\:\\ 0\\.00649454211873955\ \(0\)\
\-\ and\\:\\ 0\\.0055387386379144145\ \(0\)\
\-\ pain\\:\\ 0\\.00535183675656787\ \(0\)\
\-\ right\\:\\ 0\\.004623752354412394\ \(0\)\
\-\ of\\:\\ 0\\.00418218772095343\ \(0\)\
\-\ a\\:\\ 0\\.004067690275062577\ \(0\)\
\-\ with\\:\\ 0\\.0036001284950735305\ \(0\)\
\-\ the\\:\\ 0\\.0028358827631512983\ \(0\)\
\-\ \\.\\:\\ 0\\.002366635739823085\ \(0\)\
